سعر كارفيبرس 12.5 مجم 20 قرص 2022

Carvedilol 12.5 mg tablets, 20 tablets (Carvipress) by Global Napi Pharmaceuticals.

• Treatment of mild to severe chronic heart failure; left ventricular dysfunction following myocardial infarction in clinically stable patients; hypertension (US carvedilol tablets).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Bronchial asthma or related bronchospastic conditions; second- or third-degree AV block / sick sinus syndrome without pacemaker; severe bradycardia; cardiogenic shock; decompensated heart failure requiring IV inotropes; severe hepatic impairment; hypersensitivity.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• May worsen heart failure during initiation; abrupt withdrawal can exacerbate angina/MI; masks hypoglycemia; caution in diabetes and peripheral vascular disease.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• CYP2D6 inhibitors (e.g. fluoxetine, quinidine)May increase carvedilol exposure.DailyMed (U.S. National Library of Medicine)
• Calcium channel blockers, digoxinAdditive bradycardia/AV block risk; monitor.DailyMed (U.S. National Library of Medicine)

• Use in pregnancy only if potential benefit justifies potential risk; beta-blockers may cause fetal/neonatal bradycardia and hypoglycemia (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Carvedilol: Blocks alpha-1, beta-1 and beta-2 adrenergic receptors; reduces cardiac workload and peripheral resistance.